Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states
Pfizer has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements. Libby Hogan reports.
UP NEXT
UP NEXT
-
Exclusive: International COVID-19 vaccine poll shows higher mistrust of Russia, China shots
Reuters
-
WHO team arrives in China's Wuhan to investigate COVID-19 origins
Reuters
-
COVID-19 infection gives some immunity, but virus can still be spread, study finds
Reuters
-
Second year of pandemic 'could even be tougher': WHO's Ryan
Reuters
-
Indonesia launches vaccination drive as COVID-19 deaths hit record
Reuters
-
China sees growing COVID-19 threat as more cities locked down
Reuters
-
U.S. to require negative COVID-19 tests for arriving international air passengers
Reuters
-
EU wraps preliminary talks to buy 60 million Valneva COVID vaccines
Reuters
-
Gorillas at San Diego Zoo Safari Park diagnosed with COVID-19
Reuters
-
Two gorillas at San Diego Zoo test positive for COVID-19
Reuters
-
BioNTech lifts 2021 COVID-19 vaccine output target to 2 billion doses
Reuters
-
UK steps up vaccinations as COVID surges, worst weeks still to come
Reuters
-
Britain approves Moderna's COVID-19 vaccine, eyes spring rollout
Reuters
-
EU says it has secured nearly half of Pfizer's 2021 global output of COVID-19 shots
Reuters
-
Amid COVID-19 surge, S.Africa aims to vaccinate for herd immunity
Reuters
-
Moderna CEO says vaccine likely to protect for 'couple of years'
Reuters